EI
XENT

EAM Investors’s Intersect ENT, Inc XENT Stock Holding History

EAM Investors’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-107,395
Closed -$4.22M – 381
2018
Q1 		$4.22M Buy
107,395
+76,111
+243% +$2.78M 0.7% 17
2017
Q4 		$1.01M Sell
31,284
-132,983
-81% -$3.99M 0.18% 196
2017
Q3 		$5.12M Buy
164,267
+1,776
+1% +$52.6K 0.68% 26
2017
Q2 		$4.54M Buy
+162,491
New +$3.68M 0.75% 12
2015
Q4 		– Sell
-131,422
Closed -$3.08M – 370
2015
Q3 		$3.08M Sell
131,422
-32,492
-20% -$897K 0.49% 54
2015
Q2 		$4.69M Buy
163,914
+111,009
+210% +$2.91M 0.55% 37
2015
Q1 		$1.37M Buy
+52,905
New +$1.21M 0.16% 247

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EAM Investors's XENT Position: Q2 2018 in Review

EAM Investors sold out of Intersect ENT, Inc (XENT) in Q2 2018, closing a stake of 107,395 shares — an estimated $4.22M sold.

EAM Investors first reported a position in XENT in Q1 2015 and held it in 7 quarters. The position peaked at $5.12M in Q3 2017. 160 funds tracked by Wall St. Rank hold XENT as of Q2 2018.

  • EAM Investors reported no remaining Intersect ENT, Inc position as of Q2 2018 after selling out during the quarter.
  • EAM Investors sold 107,395 Intersect ENT, Inc shares in Q2 2018, an estimated $4.22M.
  • EAM Investors first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 7 quarters.
  • EAM Investors's Intersect ENT, Inc position peaked at $5.12M in Q3 2017.
  • 160 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2018.

Based on EAM Investors's 13F filing for Q2 2018, filed 3 Aug 2018.